Subscribe to Newsletter

October 2024 Issue of The Medicine Maker

To celebrate The Medicine Maker’s 10-year anniversary, our cover story feature showcases views on what the industry could look like in the future. Key trends include AI, personalized medicine, and the continued expansion of smart manufacturing. We also take a look at Civica Rx’s nonprofit model, how metabolic conditioning can improve the potency of cell therapies, and sit down with Stella Vnook of Likarda.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Discovery & Development Drug Discovery

The Virus and the Vaccine

| 5 min read

The search for an effective treatment for childhood brain cancers goes on, but a modified Herpes virus could represent a breakthrough.
Manufacture Technology and Equipment

AI in Pharma: A Game-Changer?

| Roger Palframan | 3 min read

How artificial intelligence can transform pharma manufacturing
Manufacture Advanced Medicine

The Elite Athlete Concept for Cell Therapy

| Yelena Bronevetsky, James Lim | 4 min read

How metabolic conditioning could improve cell therapy potency and persistence.
Manufacture Bioprocessing - Upstream & Downstream

A Love for Complexity: ADC Drug Development

| 4 min read

An expert from Samsung Biologics offers her perspective on the future of antibody drug conjugates.
Discovery & Development Formulation

MR Control

| Asma Patel, John McDermott | 4 min read

Developing modified release formulations can be complex – but a translational pharmaceutics approach can smooth the path
Manufacture Technology and Equipment

The Nonprofit Model for Manufacturing

| Stephanie Vine | 13 min read

Civica Rx is approaching generic drug manufacturing using a nonprofit model – and it’s working. We get the story behind their facility in Petersburg.
Manufacture Advanced Medicine

Preservation and Perseverance

| 5 min read

Sitting Down With… Stella Vnook, CEO, Likarda

Other issues of 2024